Zimmer target upped to $158 from $150 by Wells Fargo

Maintains Outperform

https://www.benzinga.com/stock/ZBH/ratings

WellCare cut to Equal Weight from Overweight by Stephens

Target to $317 from $330

https://www.benzinga.com/stock/WCG/ratings

resTORbio started at Overweight by Cantor

Target $23

https://www.benzinga.com/stock/TORC/ratings

PhaseBio target cut to $17 from $20 by Stifel

Maintains Buy

https://www.benzinga.com/stock/PHAS/ratings

NextCure target raised to $44 from $27 by B of A

Maintains Buy

https://www.benzinga.com/stock/NXTC/ratings

Mirati upped to Buy from Hold by Jefferies

Target to $105 from $89

https://www.benzinga.com/stock/MRTX/ratings

Mallinckrodt target cut to $8 from $20 by Stifel

Maintains Hold

https://www.benzinga.com/stock/MNK/ratings